Organo Corp. (6368) AI Stock Analysis

• Market Cap: ¥410.71B
• Dividend Yield: 1.99%
• Average Volume (3M): 189.41K
• Price to Earnings (P/E): 17.0
• Beta (1Y): 1.53
• Revenue Growth: 8.59%
• EPS Growth: 39.41%
• Country: JP
• Employees: 2,512
• Sector: Industrials
• Sector Strength: 85
• Industry: Industrial - Pollution & Treatment Controls
• EPS (TTM): 221.56
• Shares Outstanding: 46,359,700
• 10 Day Avg. Volume: 190,760
• 30 Day Avg. Volume: 189,410
• PEG Ratio: 0.51
• Price to Book (P/B): 1.92
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -8.27
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 73 Outperform
• Price Target: ¥9,701.00 ▲(8.39%Upside)

Organo Corp.'s strong financial performance and stable valuation are significant positives, supporting the stock's attractiveness. While technical indicators suggest overbought conditions, they also confirm strong momentum, which could sustain upward price movement in the medium term.

Organo Corp. Business Overview & Revenue Model

Company Description

Organo Corp. (6368) is a leading Japanese company specializing in water treatment solutions and chemical products. It operates primarily in the industrial, environmental, and municipal sectors, offering a wide range of products and services that include water purification systems, wastewater treatment, and various chemical solutions. The company's core offerings are designed to help industries achieve efficient water usage and compliance with environmental regulations.

How the Company Makes Money

Organo Corp. generates revenue through the sale and service of its water treatment systems and chemical products. Its key revenue streams include the installation and maintenance of water purification and wastewater treatment systems for industrial clients, as well as the sale of specialized chemical products used in these processes. The company also engages in long-term service contracts with municipal and environmental clients, providing ongoing system maintenance and operational support. Additionally, strategic partnerships with other industrial firms and government entities enhance its market reach and contribute to sustained earnings.

Organo Corp. Financial Statement Overview

Summary

Organo Corp. exhibits strong financial performance with robust revenue growth, improved profit margins, solid equity position, and effective cash flow management, positioning it well for future growth.

Income Statement

Organo Corp. has shown strong revenue growth, with a consistent increase in total revenue over the years, indicating a positive trajectory. The gross profit margin has improved, reflecting efficient cost management. Notably, the net profit margin has strengthened markedly, showcasing enhanced profitability. EBIT and EBITDA margins have also shown consistent improvement, underscoring robust operational performance.

Balance Sheet

The balance sheet of Organo Corp. reveals a solid equity position, with a favorable equity ratio indicating financial stability. The debt-to-equity ratio is within a reasonable range, suggesting manageable leverage levels. Additionally, the company has shown a strong return on equity, reflecting effective utilization of shareholder funds and solid profitability.

Cash Flow

Organo Corp.'s cash flow statement indicates a strong recovery in operating cash flow, supporting a positive free cash flow trend. The operating cash flow to net income ratio is robust, confirming effective cash conversion. Meanwhile, the free cash flow to net income ratio has improved, signaling efficient capital management despite past fluctuations.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	159.82B	163.27B	150.36B	132.43B	112.07B	100.64B
Gross Profit	51.31B	55.18B	43.84B	34.98B	28.51B	26.33B
EBITDA	30.97B	34.53B	25.88B	17.04B	12.18B	10.79B
Net Income	21.03B	24.15B	17.31B	11.73B	9.21B	7.07B
Balance Sheet
Total Assets	178.97B	194.40B	182.70B	164.85B	130.51B	115.01B
Cash, Cash Equivalents and Short-Term Investments	47.17B	16.75B	17.64B	25.41B	31.49B	22.58B
Total Debt	38.33B	22.56B	36.47B	33.02B	15.63B	16.00B
Total Liabilities	84.45B	73.20B	80.56B	78.48B	54.50B	47.65B
Stockholders Equity	94.28B	120.95B	101.93B	86.17B	75.84B	67.21B
Cash Flow
Free Cash Flow	0.00	26.54B	2.08B	-19.99B	7.99B	-5.84B
Operating Cash Flow	0.00	28.80B	3.73B	-18.54B	10.79B	-4.58B
Investing Cash Flow	0.00	-2.13B	-1.42B	-1.31B	-1.52B	-1.26B
Financing Cash Flow	0.00	-20.82B	-641.00M	14.71B	-2.59B	4.93B

Organo Corp. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 8950.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6368, the sentiment is Positive. The current price of 8950 is above the 20-day moving average (MA) of 8472.00, above the 50-day MA of 7838.40, and above the 200-day MA of 7541.40, indicating a bullish trend. The MACD of 348.46 indicates Negative momentum. The RSI at 70.94 is Negative, neither overbought nor oversold. The STOCH value of 71.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6368.

Organo Corp. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6331	79 Outperform	¥45.61B	9.10	13.39%	1.95%	23.92%	-9.51%
9551	77 Outperform	¥80.49B	14.21	8.79%	2.35%	8.17%	-0.38%
6370	76 Outperform	$644.61B	31.75	6.03%	1.60%	6.25%	-30.48%
6332	76 Outperform	¥85.96B	13.09		5.13%	12.10%	148.20%
6368	73 Outperform	¥410.71B	17.04		1.99%	8.59%	39.41%
6013	71 Outperform	$159.92B	15.34	9.36%	3.72%	1.34%	20.86%
Sector *	71 Outperform	¥252.71B	13.07	8.49%	3.07%	6.30%	13.10%

Organo Corp. Corporate Events

Organo Corporation Transfers Shares to Enhance Indonesian Water Treatment Venture

Organo Corporation announced its decision to transfer part of its shareholding in its Indonesian joint venture, PT Lautan Organo Water, to its partner’s subsidiary, PT Lautan Air Indonesia. This move is aimed at boosting the synergy and growth potential of the water treatment business in Indonesia, following slower than expected growth. Organo Corporation will retain a 30% stake in the venture, continuing its involvement in the water treatment sector while optimizing its business portfolio.